HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Translational and Clinical Cancer Research
Translational and Clinical Cancer Research
- Liquid Biopsies and Biomarker Discovery
- Role of Artificial Intelligence in Cancer Diagnostics
- Innovative Clinical Trial Designs in Oncology
- Real-World Data and Evidence in Cancer Treatment
Translational and clinical cancer research plays a vital role in turning laboratory discoveries into real-world medical treatments. This field focuses on applying insights from basic science to develop novel therapies, aiming to enhance the quality of patient care. It encompasses the exploration of cancer mechanisms, the identification of potential biomarkers, and the testing of treatments through clinical trials. By bridging the gap between research and patient care, this approach fosters the creation of targeted therapies that are both innovative and personalized. As a result, translational and clinical research accelerates the delivery of cutting-edge cancer treatments to patients in need.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2026 Speakers
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India